期刊文献+

皮质下缺血性血管病患者血清胆红素和尿酸水平与认知损害的关系 被引量:13

Relationship between serum bilirubin, uric acid and cognition impairment in patients with subcortical ischemic vascular disease
原文传递
导出
摘要 目的 探讨皮质下缺血性血管病(SIVD)患者血清胆红素和尿酸水平的变化及其与认知损害之间的关系.方法 将161例SIVD患者按认知损害程度分为皮质下血管性轻度认知损害组(SVMCI,n =79)及皮质下血管性痴呆组(SVaD,n=82),77名认知功能正常的老年人作为对照组.测定其血清直接胆红素(DBIL)、间接胆红素(IBIL)、总胆红素和尿酸水平;进行简易精神状态检查(MMSE)及剑桥老年认知检查表-中国修订版(CAMCOG-C)等神经心理学评价;依据头颅MRI表现对SIVD患者白质疏松程度进行分级.比较各组间血清胆红素和尿酸水平的变化,并将认知功能评分(MMSE评分)与胆红素、尿酸及血管危险因素进行多元回归分析.结果 SVaD和SVMCI患者MMSE评分(17.9±5.01、24.84±1.57)及CAMCOG-C评分(59.87±12.89、83.66±4.79)均低于对照组(28.19±1.03、91.66 ±4.93),差异均具有统计学意义(Z=197.63,P=0.000;Z=186.54,P=0.000).在校正性别、年龄及体重指数等因素后,SVaD患者的血清DBIL、IBIL和总胆红素水平均显著低于对照组;SVMCI组IBIL水平低于对照组,差异具有统计学意义.SVMCI和SVaD患者血清尿酸水平均显著高于对照组.对SIVD患者进行相关分析发现,胆红素与CAMCOG-C评分子项中语言及近记忆得分呈正相关(r=0.130,P=0.045;r =0.160,P=0.014);尿酸与MMSE、CAMCOG-C评分呈负相关(r=-0.180,P=0.005;r=-0.203,P=0.002).在控制性别、年龄、受教育程度、体重指数及高血压、糖尿病、吸烟等相关血管危险因素后,尿酸与MMSE之间仍存在一定的负性相关关系(β=-0.121,P=0.044),当进一步校正白质疏松分级后,尿酸与MMSE之间的关系并不显著.结论 SIVD患者血清胆红素水平显著降低,且与认知功能呈正相关;而尿酸水平显著增高,与认知功能呈负相关,尿酸对SIVD患者认知损害的影响与白质疏松程度密切相关. Objective To detect the levels of serum bilirubin and uric acid as well as their relationship with cognitive function in patients with subcortical ischemic vascular disease (SIVD).Methods Serum direct bilirubin (DBIL),indirect bilirubin (IBIL),total bilirubin (TBIL),uric acid (UA) and vascular risk factors were analyzed in 238 individuals comprising 161 patients with SIVD and 77 controls with normal cognitive function.SIVD patients were divided into two subgroups:those with cognitive impairment (SVMCI) and those with dementia (SVaD).All of them were subject to the cognitive assessment including Mini-mental State Examination(MMSE),the Cambridge Cognitive Examination-Chinese Version (CAMCOGC) and Clinical Demential Rating (CDR).Leukoaraiosis was graded according to the severity by their MRI scan appearances.Results MMSE and CAMCOG scores were significant lower in SVMCI and SVaD groups (17.9 ± 5.01,59.87 ± 12.89 ; 24.84 ± 1.57,83.66 ± 4.79) when compared to those in the controls (28.19 ± 1.03,91.66-± 4.93 ; Z =197.63,P =0.000 ; Z =186.54,P =0.000).In comparison with the controls,serum levels of DBIL,IBIL,and TBIL in SVaD group were significant lower ((2.85 ± 1.09) μmol/L vs (3.24 ± 1.30) iμmol/L; (7.50 ±3.27) μmol/L vs (9.06 ±3.52) μmol/L; (10.37 ±4.10) μ mol/L vs (12.31 ±4.64) μmol/L; P =0.035,P =0.005,P =0.006).Also,serum IBIL level was significant lower in SVMCI group compared to the controls ((7.86 ± 3.28) μmol/L vs (9.06 ± 3.52) μmol/L,P =0.034).While serum level of UA was significantly higher in SVMCI ((341.47 ± 92.80) μmol/L) and SVaD ((356.34 ±80.89) μmol/L) groups as compared to those in controls((310.52 ±79.85) μmol/L;P =0.025 ;P =0.001).The UA level was negatively correlated with MMSE scores and CAMCOG-C scores (r =-0.180,P =0.005; r =-0.203,P =0.002),while the bilirubin level was positively correlated with language (r =0.130,P =0.045) and recent memory (r =0.160,P =0.014) scores in CAMCOG-C.The UA level remained associated with MMSE after controlling for age,sex,education,hypertension,diabetes,smoking,and BMI (β =-0.121,P =0.044).While,after adjusting grading of a leukoaraiosis,UA has no significant association with MMSE.Conclusions The bilirubin level is decreased while the UA level is elevated in SIVD patients.The serum TBIL is negatively correlated with cognition dysfunction,while UA is strongly related to cognition dysfunction in SIVD patients.Cognitive dysfunction resulting from UA might have close association with leukoaraiosis.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2014年第5期305-310,共6页 Chinese Journal of Neurology
关键词 脑缺血 大脑皮质 痴呆 血管性 胆红素 尿酸 认知障碍 Brain ischemia Cerebral cortex Dementia, vascular Bilirubin Uric acid Cognition disorders
  • 相关文献

参考文献25

  • 1Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments [ J ]. Lancet Neurol, 2008, 7: 246-255.
  • 2Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance [ J ]. Science, 1987, 235 : 1043-1046.
  • 3Hooper DC, Spitsin S, Kean RB, et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis [ J ]. Proc Natl Acad Sci U S A,1998, 95: 675-680.
  • 4Spitsin S, Koprowski H. Role of uric acid in Alzheimer' s disease [J]. J Alzheimers Dis, 2010, 19: 1337-1338.
  • 5李丹,王晓君,罗蔚锋,朱婷鸽,胡伟东,毛成洁,刘春风.尿酸对帕金森病患者不同认知功能域影响分析[J].中华神经科杂志,2010,43(6):400-402. 被引量:15
  • 6Schretlen DJ, Inscore AB, Vannorsdall TD, et al. Serum uric acid and brain ischemia in normal elderly adults [ J ]. Neurology, 2007, 69: 1418-1423.
  • 7Park B J, Shim JY, Lee HR, et al. Association between serum total bilirubin level and leukoaraiosis in Korean adults [ J ]. Clin Biochem, 2012, 45: 289-292.
  • 8Erkinjuntti T. Subcortical vascular dementia [ J ]. Cerebrovasc Dis, 2002, 13 Suppl 2: 58-60.
  • 9中华医学会神经病学分会痴呆与认知障碍学组写作组.血管性认知障碍诊治指南[J].中华神经科杂志,2011,44:142-147.
  • 10Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia[J]. Lancet Neurol, 2002, 1 : 426-436.

二级参考文献39

  • 1Hughes TA,Ross HF,Musa S,et al.A 10-year study of the incidence of and factors predicting dementia in Parkinson ' s disease.Neurology,2000,54:1596-1602.
  • 2Emre M.Dementia associated with Parkinson' s disease.Lancet Neurol,2003,2:229-237.
  • 3de Lau LM,Koudstaal PJ,Hofman A,et al.Serum uric acid levels and the risk of Parkinson disease.Ann Neurol,2005,58:797-800.
  • 4Annanmaki T,Muuronen A,Murros K.Low plasma uric acid level in Parkinson' disease.Mov Disord,2007,22:1133-1137.
  • 5Meara J,Bhowmick BK,Hobson P.Accuracy of diagnosis in patients with presumed Parkinson' s disease.Age Ageing,1999,28:99-102.
  • 6Nazem S,Siderowf AD,Duda JE,et al.Montreal cognitive assessment performance in patients with Parkinson' s disease with " normal " global cognition according to mini-mental state examination score.J Am Geriatr Soc,2009,57:304-308.
  • 7Ismail Z,Rajji TK,Shulman KI.Brief cognitive screening instruments:an update.Int J Geriatr Psychiatry,2010,25:111-120.
  • 8Zgaljardic DJ,Borod JC,Foldi NS,et al.A review of the cognitive and behavioral sequelae of Parkinson ' s disease:relationship to frontostriatal circuitry.Cogn Behav Neurol,2003,16:193-210.
  • 9de la Monte SM,Canju N,Feroz N,et al.Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells.J Alzheimers Dis,2000,2:261-281.
  • 10Maiese K,Chong ZZ.Insights into oxidative and potential novel therapeutic targets for Alzhermer disease.Restor Neurol Neurosci,2004,22:87-104.

共引文献296

同被引文献108

  • 1蔡川奇,林志鸿,蔺佩鸿,江勇,郭平清.血清白蛋白和前白蛋白对老年肺炎病情的预测价值[J].中国老年学杂志,2014,34(1):103-105. 被引量:30
  • 2贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:266
  • 3王炜,王鲁宁.“蒙特利尔认知评估量表”在轻度认知损伤患者筛查中的应用[J].中华内科杂志,2007,46(5):414-416. 被引量:254
  • 4Buratti L, Balestrini S, Altamura C, et al. Markers for the risk of progression from mild cognitive impairment to Alzheimer' s disease [J]. J Alzheimers Dis, 2015,45(3) :883-890.
  • 5Portet F, Ousset OJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice:a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease [J]. J Neurol Neurosurg Psychiatry, 2006,77(6) :714-718.
  • 6Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment:clinical characterization and outcome [J]. Arch Neurol, 1999,56(3) : 303-308.
  • 7Brodaty H, Heffernan M, Koehan NA, et al. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study [J]. Alzheimers Dement, 2013,9(3) :310-317.
  • 8Cervellati C, Cremonini E, Bosi C, et al. Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease [J]. Curr Alzheimer Res, 2013,10 (4) : 365-372.
  • 9Cervellati C, Romani A, Seripa D, et al. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzbeimer's Disease or Vascular Dementia [ J ]. J Neurol Sci, 2014,337(1-2) : 156-161.
  • 10Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer's disease [J]. Int J Geriatr Psychiatry, 2006,21 (d) : 344-348.

引证文献13

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部